Diterpenoid natural compound C4 (Crassin) exerts cytostatic effects on triple-negative breast cancer cells via a pathway involving reactive oxygen species
CE Richards, SH Vellanki, YE Smith, AM Hopkins - Cellular Oncology, 2018 - Springer
Purpose Triple-negative breast cancers (TNBC) lack expression of three common cell
surface receptors, ie, estrogen receptor (ER), progesterone receptor (PR) and human …
surface receptors, ie, estrogen receptor (ER), progesterone receptor (PR) and human …
[HTML][HTML] Arnicolide d inhibits triple negative breast cancer cell proliferation by suppression of Akt/mTOR and STAT3 signaling pathways
Z Qu, Y Lin, DKW Mok, Q Bian, WCS Tai… - International Journal of …, 2020 - ncbi.nlm.nih.gov
Abstract Triple-Negative Breast Cancer (TNBC) is a most dangerous breast cancer subtype.
The naturally occurring sesquiterpene lactone, arnicolide D (AD), has proven effective …
The naturally occurring sesquiterpene lactone, arnicolide D (AD), has proven effective …
Arachidin-1, a prenylated stilbenoid from peanut, induces apoptosis in triple-negative breast cancer cells
S Mohammadhosseinpour, LC Ho, L Fang… - International Journal of …, 2022 - mdpi.com
Triple-negative breast cancer (TNBC) is unresponsive to typical hormonal treatments,
causing it to be one of the deadliest forms of breast cancer. Investigating alternative …
causing it to be one of the deadliest forms of breast cancer. Investigating alternative …
Brevilin A, a natural sesquiterpene lactone inhibited the growth of triple-negative breast cancer cells via Akt/mTOR and STAT3 signaling pathways
Z Qu, Y Lin, DKW Mok, Q Bian, WCS Tai… - OncoTargets and …, 2020 - Taylor & Francis
Purpose Triple-negative breast cancer (TNBC) is aa breast cancer subtype characterized by
a lack of estrogen receptor, progesterone receptor and human epidermal growth receptor 2 …
a lack of estrogen receptor, progesterone receptor and human epidermal growth receptor 2 …
[HTML][HTML] Phytoagent deoxyelephantopin derivative inhibits triple negative breast cancer cell activity by inducing oxidative stress-mediated paraptosis-like cell death
JY Shiau, K Nakagawa-Goto, KH Lee, LF Shyur - Oncotarget, 2017 - ncbi.nlm.nih.gov
Triple negative breast cancer (TNBC) is a highly metastatic cancer among the breast cancer
subgroups. A thorny issue for clinical therapy of TNBC is lack of an efficient targeted …
subgroups. A thorny issue for clinical therapy of TNBC is lack of an efficient targeted …
The potential of natural products in the treatment of triple-negative breast cancer
DYJ Ke, S El-Sahli, L Wang - Current cancer drug targets, 2022 - benthamdirect.com
Triple-negative breast cancer (TNBC) is a subtype of breast cancer that lacks receptors for
targeted therapy. Consequently, chemotherapy is currently the mainstay of systemic …
targeted therapy. Consequently, chemotherapy is currently the mainstay of systemic …
Antitumor Activity of Vanicoside B Isolated from Persicaria dissitiflora by Targeting CDK8 in Triple-Negative Breast Cancer Cells
A flavonoid glycoside, quercitrin (1), and two phenylpropanoyl sucrose derivatives,
vanicoside B (2) and lapathoside C (3), were isolated for the first time from the herb …
vanicoside B (2) and lapathoside C (3), were isolated for the first time from the herb …
4-Acetylantroquinonol B induced DNA damage response signaling and apoptosis via suppressing CDK2/CDK4 expression in triple negative breast cancer cells
PB Satriyo, CM Su, JR Ong, WC Huang, IH Fong… - Toxicology and Applied …, 2021 - Elsevier
Background Triple-negative breast cancer (TNBC) has a more aggressive phenotype and
poorer prognosis than hormone receptor (HR+) and human epidermal growth factor receptor …
poorer prognosis than hormone receptor (HR+) and human epidermal growth factor receptor …
Sesquiterpenoids from Inula britannica and Their Potential Effects against Triple-Negative Breast Cancer Cells
RY Qi, C Guo, XN Peng, JJ Tang - Molecules, 2022 - mdpi.com
Flowers of Inula britannica commercially serve as pharmaceutical herbs in the
manufacturing of medicinal products. In the current study, sesquiterpenoids of I. britannica …
manufacturing of medicinal products. In the current study, sesquiterpenoids of I. britannica …
SH003 and Docetaxel Show Synergistic Anticancer Effects by Inhibiting EGFR Activation in Triple‐Negative Breast Cancer
Although many anticancer drugs have been developed for triple‐negative breast cancer
(TNBC) treatment, there are no obvious therapies. Moreover, the combination of epidermal …
(TNBC) treatment, there are no obvious therapies. Moreover, the combination of epidermal …